QNCX Financials
Quince Therapeutics, Inc. - Financial statements & key metrics
Stock Price
$32.11
Market Cap
$79.25M
P/E Ratio
-24.5
EPS
$-1.20
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-56.83M
EPS (Diluted)
$-1.31
Balance Sheet Highlights
Total Assets
$114.48M
Total Liabilities
$84.33M
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-31.90M
CapEx
-
Free Cash Flow
-
Profitability Metrics
00
ROE
-247.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is QNCX revenue?
View QNCX's income statement for detailed revenue data.
Is QNCX profitable?
QNCX reported a loss of $56.83M in the most recent quarter.
What is QNCX market cap?
QNCX has a market capitalization of $79.25M, making it a small-cap stock.
Does QNCX have debt?
View QNCX's balance sheet for debt information.
What is QNCX cash flow?
Cash flow data is available in the full financial statements.